• Transpire Bio opens R&D facility in China

  US-based Transpire Bio announced that it has opened an R&D facility in Shanghai, China with approximately 40 employees who will work on development of generic OINDPs for the UK, European, and Asian Pacific markets. Transpire… [Read more . . .]

• FDA approves AstraZeneca’s Breztri Aerosphere budesonide / glycopyrrolate / formoterol MDI for the treatment of asthma

  AstraZeneca announced that the FDA has approved the company’s Breztri Aerosphere budesonide / glycopyrrolate / formoterol MDI for the treatment of asthma in patients aged 12 and older. The agency originally approved Breztri for the treatment of… [Read more . . .]

• Avalyn Pharma announces appointments of Adam Golden as Head of Business Development and Frank Salisbury as Senior VP, Commercial

  Inhaled drug developer Avalyn Pharma has announced the appointments of attorney Adam Golden as General Counsel and Head of Business Development and pharma sales and marketing veteran Frank Salisbury as Senior VP, Commercial. Golden was… [Read more . . .]

• FDA approves Cipla’s generic of Ventolin HFA albuterol MDI

  Cipla has received FDA approval of its ANDA for a generic version of Ventolin HFA albuterol MDI for the treatment of asthma, the company announced. GSK’s NDA Ventolin HFA was approved by the agency in… [Read more . . .]

• Rocket Science Health gets additional US patent covering its nasal delivery technology

  Rocket Science Health announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 12,569,658, titled “Dual Nozzles For Insertion Into Paired Body Orifices (e.g., Nasal Passages, Etc.)” covering the company’s intranasal… [Read more . . .]

• Vistagen gets go-ahead for Phase 2 trial of refisolone (PH-80) nasal spray for the treatment of hot flashes

• FDA extends review of Savara’s BLA for Molbreevi molgramostim inhalation solution for the treatment of aPAP

• ARS Pharma and ALK announce that Health Canada has approved neffy epinephrine nasal spray

• Amneal launches generic versions of ProAir HFA albuterol MDI and QVAR beclomethasone MDI in the US

• Iconovo names Anders Månsson as permanent CEO

More news . . .